United States securities and exchange commission logo





                           May 11, 2022

       Trevor Bezkdek
       Co-Chief Executive Officer
       GoodRx Holdings, Inc.
       2701 Olympic Boulevard
       Santa Monica, CA 90404

                                                        Re: GoodRx Holdings,
Inc.
                                                            Form 10-K For the
Fiscal Year Ended December 31, 2021
                                                            Response dated
April 25, 2022
                                                            File No. 001-39549

       Dear Mr. Bezkdek:

              We have reviewed your April 25, 2022 response to our comment
letter and have the
       following comment. In some of our comments, we may ask you to provide us
with information
       so we may better understand your disclosure.

              Please respond to this comment within ten business days by
providing the requested
       information or advise us as soon as possible when you will respond. If
you do not believe our
       comment applies to your facts and circumstances, please tell us why in
your response.

              After reviewing your response to the comment, we may have
additional
       comments. Unless we note otherwise, our references to prior comments are
to comments in our
       April 18, 2022 letter.

       Form 10-K for the Fiscal Year Ended December 31, 2021

       Notes to Consolidated Financial Statements
       14. Stockholders Equity
       Restricted Stock Units for Class B Common Stock, page F-29

   1.                                                   We note your response
to our comment three. In this regard, please provide us with your
                                                        accounting analysis as
to whether any in-substance service conditions exists for the
                                                        Performance-Vesting
Founders Award RSU   s. Your response should address but not be
                                                        limited to the
following points.
                                                            Tell us if there
are any provisions or conditions, whether in the award or elsewhere,
                                                             that compels the
employees to remain in employment after the vesting date in order
                                                             to receive the
award.
                                                            Tell us if there
exists any risk of forfeiture after the vesting date. We note your
 Trevor Bezkdek
GoodRx Holdings, Inc.
May 11, 2022
Page 2
              disclosure on page 48 that    FICA taxes are generally due in the
period when the
              substantial risk of forfeiture lapses.    If a risk of forfeiture
exists, explain how you
              considered the forfeiture conditions in evaluating whether any
in-substance service
              conditions exist.
                We note your statement on page 48 that,    As the
Performance-Vesting Founders
              Awards vested in October 2020, we accelerated the settlement of
0.7 million RSUs
              during the fourth quarter of 2020 sufficient to satisfy FICA tax
withholding
              obligations due in the year of vesting.    Provide us an analysis
of your accounting,
              with appropriate citation to authoritative literature, for the
acceleration and any other
              modification since the original grant date of the awards.
                We note your response states that a    three-year settlement
deferral period was
              negotiated to postpone the potentially significant cash
expenditure for the Company
              associated with these payments.    Tell us whether this
negotiation occurred before or
              after grant date. If the negotiation occurred after grant date,
provide us with your
              accounting analysis, with appropriate citation to authoritative
literature, for the effect
              of the modification.
                We note that at the same time you issued your
Performance-Vesting Founders
              Awards, you also issued Time-Vesting Founders Awards that vest in
equal quarterly
              installments over four years. Provide us with your accounting
analysis of the
              consideration you gave to whether the four year explicit service
condition for your
              time vested restricted awards represents an in-substance service
condition for the
              performance based awards.

        You may contact Inessa Kessman, Senior Staff Accountant at 202-551-3371
or Robert
Littlepage, Accounting Branch Chief at 202-551-3361 if you have questions
regarding comments
on the financial statements and related matters.



FirstName LastNameTrevor Bezkdek                                 Sincerely,
Comapany NameGoodRx Holdings, Inc.
                                                                 Division of
Corporation Finance
May 11, 2022 Page 2                                              Office of
Technology
FirstName LastName